GGrantIndex
← Leaderboards

Ning Huang

Ventria Bioscience

$4,589,522
Attributed
$4,589,522
Total exposure
12
Grants
11
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.4M · FY200514
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14

Funding mix

By agency

NIH$4,589,522 · 12

By mechanism

R44$3,135,592 · 3
R43$1,453,930 · 9

Top collaborators

No co-investigators on record.

Others in their field

Top investigators on “Production

Research focus

ProductionRiceCerealsBaseProteinsSmall Business Innovation Research GrantRecombinantsPublic Health RelevanceMarketingEffectivenessScale UpOral AdministrationVaccinesInfectionAnimalsGrowthPreventSafetyRecombinant ProteinsOralTransmission ProcessElderlyPathogenPlants

Grant awards (17)

Low-cost production of rApoA-IM for the treatment of cardiovascular disease$260,890
R43 · FY2014 · HL · contact PI
Production of human MUC17 (CRD1-L-CRD2) recombinant protein in rice for the treat$237,323
R43 · FY2013 · DK · contact PI
Lactoferrin for the prevention of antibiotic-associated diarrhea in adult$420,843
R44 · FY2012 · AG · contact PI
Production of OspA in rice for the control of Lyme disease$286,601
R44 · FY2012 · AI · contact PI
Lactoferrin for the prevention of antibiotic-associated diarrhea in adult$413,160
R44 · FY2011 · AG · contact PI
Production of OspA in rice for the control of Lyme disease$296,879
R44 · FY2011 · AI · contact PI
Low cost production of rabies virus antigens in rice grain$226,554
R43 · FY2011 · AI · contact PI
Lactoferrin for the prevention of antibiotic-associated diarrhea in adult$538,324
R44 · FY2010 · AG · contact PI
Production of OspA in rice for the control of Lyme disease$455,157
R44 · FY2010 · AI · contact PI
Recombinant Human Serum Albumin for Use in Cell Culture$377,948
R44 · FY2010 · GM · contact PI
Recombinant Human Serum Albumin for Use in Cell Culture$346,680
R44 · FY2009 · GM · contact PI
Production of OspA in rice for the control of Lyme Disease$126,530
R43 · FY2009 · AI · contact PI
Recombinant human serum albumin for use in cell culture media$99,982
R43 · FY2007 · GM · contact PI
Recombinant human defensin for management of ileal Crohn's disease$189,300
R43 · FY2006 · AI · contact PI
Use of recombinant human lactoferrin for wounds by stimulating cell growth$113,851
R43 · FY2006 · GM · contact PI
Recombinant human serum albumin for therapeutic use$99,500
R43 · FY2006 · HL · contact PI
Lactoferrin prevents biofilm formation at wound$100,000
R43 · FY2005 · AG